Literature DB >> 8381465

Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designated gC-II.

B Kari1, R Gehrz.   

Abstract

The structure and heparin binding properties of a family of human cytomegalovirus (HCMV) disulphide-linked glycoprotein complexes designated gC-II were analysed. gC-II complexes contain two groups of glycoproteins designated Group 1 and Group 2. These glycoproteins were separated from each other by short exposure of virions to a reducing agent. This showed that the disulphide bonds between these glycoproteins were on the external surface of the virion. Although these glycoproteins were no longer associated they were not released from the virion, suggesting that they were transmembrane glycoproteins. Approximately 75 to 90% of the gC-II complexes and 18% of the complexes containing the HCMV gB glycoprotein obtained from the virion envelope bound immobilized heparin. When virions were incubated with [3H]heparin, gC-II complexes bound more heparin than gB complexes, by approximately threefold. These data showed that gC-II complexes had a greater heparin-binding capacity. After treatment of virions with a reducing agent the affinity of gC-II glycoproteins for heparin was greatly reduced whereas the affinity of gB glycoproteins was only slightly reduced. Thus, higher order structure was important for heparin binding by gC-II complexes but not by those of gB. Relative to gC-II Group 1 glycoproteins, a greater portion of gC-II Group 2 glycoproteins still bound to heparin after reduction, suggesting that Group 2 glycoproteins may be the important heparin binding component of the gC-II complexes. Both gB and gC-II complexes were eluted from immobilized heparin with soluble heparin or 0.65 M-NaCl suggesting that both formed ionic bonds with heparin. Chondroitin sulphate was not effective at eluting HCMV envelope glycoproteins from immobilized heparin. Thus, the structure of the glucosaminoglycan backbone is important to the binding of HCMV glycoproteins to heparin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381465     DOI: 10.1099/0022-1317-74-2-255

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).

Authors:  M Mach; B Kropff; P Dal Monte; W Britt
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Postattachment events associated with viral entry are necessary for induction of interferon-stimulated genes by human cytomegalovirus.

Authors:  James R Netterwald; Thomas R Jones; William J Britt; Shao-Jun Yang; Ian P McCrone; Hua Zhu
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

3.  The Human Cytomegalovirus Trimer and Pentamer Promote Sequential Steps in Entry into Epithelial and Endothelial Cells at Cell Surfaces and Endosomes.

Authors:  Jing Liu; Ted S Jardetzky; Andrea L Chin; David C Johnson; Adam L Vanarsdall
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

Review 4.  Human cytomegalovirus entry into cells.

Authors:  Adam L Vanarsdall; David C Johnson
Journal:  Curr Opin Virol       Date:  2012-01-30       Impact factor: 7.090

5.  The porcine humoral immune response against pseudorabies virus specifically targets attachment sites on glycoprotein gC.

Authors:  B T Ober; B Teufel; K H Wiesmüller; G Jung; E Pfaff; A Saalmüller; H J Rziha
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Identification and analysis of a novel heparin-binding glycoprotein encoded by human herpesvirus 7.

Authors:  D Skrincosky; P Hocknell; L Whetter; P Secchiero; B Chandran; S Dewhurst
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Human Cytomegalovirus nuclear egress and secondary envelopment are negatively affected in the absence of cellular p53.

Authors:  Man I Kuan; John M O'Dowd; Kamila Chughtai; Ian Hayman; Celeste J Brown; Elizabeth A Fortunato
Journal:  Virology       Date:  2016-08-05       Impact factor: 3.616

8.  Coiled-coil domains in glycoproteins B and H are involved in human cytomegalovirus membrane fusion.

Authors:  Matthew Lopper; Teresa Compton
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry.

Authors:  B C Herold; S I Gerber; B J Belval; A M Siston; N Shulman
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Specific inhibition of human cytomegalovirus glycoprotein B-mediated fusion by a novel thiourea small molecule.

Authors:  Thomas R Jones; Shi-Wu Lee; Stephen V Johann; Vladimir Razinkov; Robert J Visalli; Boris Feld; Jonathan D Bloom; John O'Connell
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.